317 related articles for article (PubMed ID: 185040)
1. Drug-induced hypertension: pathogenesis and management.
Stokes GS
Drugs; 1976; 12(3):222-30. PubMed ID: 185040
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives--induced hypertension--nine years later.
Laragh JH
Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
4. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
5. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
Hollenberg NK; Williams GH; Burger B; Chenitz W; Hoosmand I; Adams DF
Circ Res; 1976 Jan; 38(1):35-40. PubMed ID: 1244226
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure changes and hormonal contraceptives.
Shen Q; Lin D; Jiang X; Li H; Zhang Z
Contraception; 1994 Aug; 50(2):131-41. PubMed ID: 7956212
[TBL] [Abstract][Full Text] [Related]
8. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
[TBL] [Abstract][Full Text] [Related]
9. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
10. Some observations on the changes in capillary resistance in oral contraceptive users.
Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
[TBL] [Abstract][Full Text] [Related]
11. [Oral contraceptives, hypertension and nephrosclerosis].
Girndt J
Fortschr Med; 1978 Feb; 96(7):327-32. PubMed ID: 627380
[TBL] [Abstract][Full Text] [Related]
12. [The pathogenesis of oral contraceptive hypertension (author's transl)].
Girndt J; Scheler F
Klin Wochenschr; 1977 Apr; 55(7):347-8. PubMed ID: 870746
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
14. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
Manuilova IA; Dubnitskaia LV; Korsakov SG
Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
[TBL] [Abstract][Full Text] [Related]
15. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
Meade TW
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935
[TBL] [Abstract][Full Text] [Related]
16. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
Weir RJ
Scott Med J; 1982 Jul; 27(3):212-5. PubMed ID: 6810459
[TBL] [Abstract][Full Text] [Related]
17. Oestrogens and hypertension.
Roberts JM
Clin Endocrinol Metab; 1981 Nov; 10(3):489-512. PubMed ID: 7047019
[TBL] [Abstract][Full Text] [Related]
18. An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
Shionoiri H; Eggena P; Barrett JD; Thananopavarn C; Golub MS; Eggena Z; Nakamura R; Judd HL; Sambhi MP
Biochem Med; 1983 Feb; 29(1):14-22. PubMed ID: 6838497
[TBL] [Abstract][Full Text] [Related]
19. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
Mann JI
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
